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Abstract  
Soft, stretchable materials hold great promise for the fabrication of biomedical devices due to their 
capacity to integrate gracefully with and conform to biological tissues. Conformal devices are of 
particular interest in the development of brain interfaces where rigid structures can lead to tissue 
damage and loss of signal quality over the lifetime of the implant. Interfaces to study brain function 
and dysfunction increasingly require multimodal access in order to facilitate measurement of diverse 
physiological signals that span the disparate temporal and spatial scales of brain dynamics. Here we 
present the Opto-e-Dura, a soft, stretchable, 16-channel electrocorticography array that is optically 
transparent. We demonstrate its compatibility with diverse optical and electrical readouts enabling 
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multimodal studies that bridge spatial and temporal scales. The device is chronically stable for weeks, 
compatible with wide-field and 2-photon calcium imaging and permits the repeated insertion of 
penetrating multi-electrode arrays. As the variety of sensors and effectors realizable on soft, 
stretchable substrates expands, similar devices that provide large-scale, multimodal access to the 
brain will continue to improve fundamental understanding of brain function. 
 
1. Introduction 
Over the past decade, rapid advances in the field of conformal electronics have brought soft, 
stretchable materials to the forefront in the design of next generation biomedical devices. In contrast 
to traditional rigid devices, they integrate well with biological tissues as a result of low mechanical 
mismatch and high conformability to curved biological structures[1–3]. Recently, soft and stretchable 
devices have been developed to interface with the central nervous system. Minev et al. introduced the 
“e-dura”, a soft, stretchable multi-electrode array to address spinal cord injuries[4] and they have 
developed a framework to pursue improved translational studies[5]. Subsequent work improved 
fabrication techniques and introduced approaches based on nanomaterials[6], hydrogel[7] or inkjet 
printing[8], and new designs such as meshes[9] and fibers[10]. Tybrandt et al. demonstrated the chronic 
stability of stretchable electrocorticography (ECoG) arrays for long-term electrical measurements 
from the cortical surface of rats for up to 3 months[11]. These developments illustrate the exciting 
possibilities that soft and stretchable electronics offer for long-term interfacing with the central 
nervous system. However, while brain function arises from a rich array of physiological signals with 
diverse dynamics across spatial and temporal scales, most current experimental approaches are 
restricted to a single measurement modality and scale[12]. Understanding brain function requires 
devices that enable the combined application of multiple tools with complementary resolution and 
coverage to link the activity of cellular processes, local networks, and patterns of global brain 
activity[13]. New devices that enable multimodal and multi-scale data acquisition will lead to a more 
complete picture of brain function and dysfunction[14]. 
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Experimentally accessible brain signals each have unique strengths and limitations. In isolation they 
provide a limited, piece-meal picture of brain function. Signals vary in terms of both spatial and 
temporal scale as well as in the cellular processes they render visible[15,16]. ECoG has rapidly become 
a core method in neuroscience because of its relatively minimal invasiveness, long-term stability, and 
temporal resolution. However, the neuronal sources that contribute to the ECoG signal are still ill-
defined, because ECoG typically lacks the specificity necessary to investigate cellular processes[17]. 
Understanding the ECoG signal is of critical importance for many clinical and basic neuroscience 
questions. It requires integration with other methods that permit monitoring of identified cell-types 
based on anatomy, physiology, and genetics[18]. Multi-electrodes arrays (MEAs) can be inserted into 
the brain enabling increased proximity to sources and direct recording of cellular-scale signals within 
local networks (single- and multi-unit activity, SUA/MUA), as well as population activity similar to 
ECoG, but more spatially localized (local field potential, LFP). New methods promise to increase the 
scale and resolution of MEA recordings[19,20], however, especially for long-term chronic studies, there 
is a trade-off between dense local sampling and large-scale sampling of distributed populations due 
to space constraints[12]. Optical imaging approaches, such as wide-field and 2-photon calcium 
imaging, enable cell type and pathway-specificity, as well as long term stability through targeted 
expression of indicators[21,22]. However, they typically have low temporal resolution, require a trade-
off between field of view, resolution and temporal sampling rate[23], and do not provide an absolute 
measurement because they are derived from changes in fluorescence. 
Various attempts have been made to bridge scales by integrating measurement modalities to provide 
comprehensive perspectives on brain activity[24–27]. However, most existing studies have been 
performed under anesthesia and the vast majority have been performed in acute preparations, where 
it is impossible to study behavior or learning. Few alternatives exist to provide stable, long-term 
access for repeated, multimodal, and multi-scale measurement from populations over behaviorally 
relevant time scales.[28,29] Such devices will open new windows on integrated brain activity by 
facilitating the application of complementary tools[30–32]. By combining ECoG measurements with 
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complementary optical and electrical methods, we aim to bridge local and distributed dynamics to 
aid understanding of brain function. 
We introduce the ‘Opto-e-Dura’, an optically transparent ECoG array that is chronically stable and 
facilitates multimodal, multi-scale experiments in combination with diverse optical and electrical 
methods. The Opto-e-Dura is constructed with a novel fabrication technique, and we demonstrate 
combined applications of the ECoG with three essential techniques in systems neuroscience: wide-
field calcium imaging, 2-photon calcium imaging, and recording from acutely inserted MEAs. The 
integration of these diverse techniques enables experiments that combine the unique strengths of each 
method. These applications demonstrate the utility of this new device to improve understanding of 
brain function in a versatile fashion in the same animal across behaviorally-relevant time scales. 
 
Figure 1. The Opto-e-Dura a) Photograph of the ECoG array before attachment of the imaging well b) Schematic 
of the device showing its size and coverage over regions of interest on the dorsal cortex of the mouse brain, c) 
Schematic cross section of the device implanted on the mouse illustrating imaging well and placement of connector 




2.1. Opto-e-Dura design 
We developed a PDMS-based ECoG array with highly porous platinum electrodes to interface 
chronically with the central nervous system based on earlier work[4,11] (Figure 1a). We sought to 
exploit two additional features of PDMS to produce a device for multimodal, multi-scale 
neuroscience. First, the optical transparency of PDMS makes it suitable as a window to facilitate 
optical measurement of brain activity[32,33]. Second, the soft, elastic nature of PDMS makes it possible 
to penetrate the membrane with penetrating MEAs and record cellular and population activity from 
deep and superficial sources[34]. We designed a 16-electrode ECoG to match the channel count of our 
amplifier headstage and to produce a compact package that would fit comfortably on the skull of a 
mouse. A compact design was especially crucial to permit adequate clearance for objective lenses 
and MEAs to approach the Opto-e-Dura after implantation. The electrode layout consists of two 
concentric circles of 8 electrodes each, covering a circular region of ~4 mm in diameter, roughly 1/3 
of the dorsal cortex in one hemisphere of an adult mouse (Figure 1b). The array can be positioned on 
the dura to permit access to a number of sensory and association areas commonly engaged in sensory 
discrimination behaviors[35] (Figure 1b). The electrodes are ring-shaped with an inner diameter of 
200 µm and an outer diameter of 400 µm. To facilitate chronic optical access, we designed the device 
to replace a portion of the cranium and integrated a PDMS imaging well to retain fluid for use with a 
water-dipping 2-photon objective lens (Figure 1c). The high conformability of the Opto-e-Dura 
allowed us to flexibly position the electrical connector to increase clearance around the ECoG while 
still connecting the necessary recording electronics. The final device provided good optical access to 
areas of interest (Figure 1d), was chronically stable for up to a month, and enabled multiple imaging 
and electrophysiological recording sessions in awake and anesthetized animals. 
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2.2. Opto-e-Dura fabrication 
The ECoG was fabricated using PDMS as a substrate and by combining gold nanowire (Au NW) 
tracks with platinum (Pt) particle electrodes in a novel push-through approach (Figure 2a). The 
process consists of three main steps: photolithography patterning of filter membranes to generate 
masks, filtration of conductive components through these masks, and embedding of the conductive 
patterns in PDMS. First, we performed photolithography on polyvinylidene fluoride (PVDF) filter 
membranes[36] to generate two masks: one for the Au NW tracks, and one for the Pt particle electrodes 
(Figure 2a). Second, the masks were sequentially placed on a filtration setup to filter a solution 
consisting of distilled water with either Au NWs or Pt particles through the respective mask (Figure 
2a). The concentration of the Pt particle solution can be tuned to control the electrode height (Figure 
S1). By using filtration instead of deposition, we reduce material waste while maintaining high-
resolution features[37]. Finally, the deposited Au NW tracks are embedded in a semi-cured PDMS 
layer after careful inspection to insure the absence of defects or short circuits. Crucially, the 2nd PDMS 
layer must be cured to a pre-defined point for successful electrode fabrication: if it is not cured long 
enough the Pt particles will diffuse into and be encapsulated by the PDMS, whereas if it is cured for 
too long it is not possible to achieve electrical contact between the electrodes and tracks. After 
aligning the membrane containing the Pt particle electrodes with the Au NW tracks on the PDMS, 
the Pt particle pillars were pushed through the 2nd PDMS layer with a uniform weight (Figure 2a) to 
bring the Pt particle electrodes into electrical contact with the Au NW tracks.  
After testing the functionality of the fully cured device, it was cut to the desired shape and mounted 
on a PCB with a connector (Figure 1a). Scanning electron microscopic (SEM) imaging revealed high 
porosity of the Pt-particle electrodes (Figure 2b) and established contact at the interface between the 
Au NWs and the Pt particles (Figure 2c-d). We fabricated devices of 33μm and 75 μm thickness by 
adapting the spin coating speed for the first PDMS layer. Here we chose to use the 75 μm devices for 
further in vivo tests to assure both stability during imaging and durability during penetration with 
linear electrode arrays. However, some applications might require thinner, more conformable devices, 
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were the 33 μm comes in handy and as both thicknesses had similar impedances, there is no drawback 
in terms of the device’s performance (Figure S2). The Young’s modulus of the final device was found 
to be in the range of 724 – 881 kPa and initial elongation test up to 20% did not impact the overall 
electrodes performance (Figure S5). 
 
Figure 2. Fabrication and characterization of the Opto-e-Dura. a) PVDF membranes are patterned with photoresist, 
Pt particles and Au NWs are filtered and sedimented in the negative space, as previously described[11]. Au NWs 
were brought in contact with PDMS before a second layer is added to insulate the tracks. Through the second PDMS 
layer the Pt particle pillars, acting as electrodes, were brought in contact with the underlying Au NWs by applying 
force. b-d) SEM images of the side cuts of the whole electrode (400 µm outer and 200 µm inner dimension) (b), the 
porous Pt particle surface with the underlying Au NWs (c) and the zoomed in Pt particle (blue) to Au NWs (yellow) 
interface (d). e) The median impedance and bode phase of implanted Opto-e-Dura devices, n=80 electrodes (94.3k 
μm2) from 5 devices. f) Stability of electrodes before (green) and after (blue) 10,000 biphasic stimulation pulses 
(200 μA for 200 μs each) n=16 electrodes. g) Spectrophotometry data of a cortex MEA, showing over 90% 
transmittance in the range suitable for wide-field imaging. h) Post-mortem histology of a mouse chronically 
implanted with an Opto-e-Dura for 6 weeks shows lack of chronic immune response to the implant. DAPI-staining 
of nuclei (blue) and immune-staining of microglia (red, anti-TMEM119) for a coronal slice through the center of 
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the Opto-e-Dura. No obvious microglia activation is discernible at the location of the array over the left hemisphere 
(left image) as compared with the control right hemisphere with no implant (right image), n=1 mouse. White line 
indicates the position of the Opto-e-Dura. 
2.3. Characterization of electrochemical performance 
The impedance spectrum of each device was measured prior to implantation and established the 
stability and reliability of the fabrication technique. First, cyclic voltammetry (CV) was performed to 
electrochemically condition the electrodes and establish a stable double layer at the electrode-
electrolyte interface. After formation of the double layer, we measured the impedance, which on 
average was 998 ± 93 Ω at 1 kHz (mean ± SD; N=80 electrodes=). The impedances of the Opto-e-
Dura electrodes at high frequencies (>1k Hz), when the resistance is the limiting factor, were 
consistent with those previously reported for PDMS-based electrodes (Figure 2e). However, 
impedances were consistently lower at lower frequencies than conventional stretchable 
electrodes(e.g., 24 Ω cm2 at 1 Hz compared to 30 Ω cm2 in Tybrandt et al.[11]). The electrochemical 
equivalent circuit can be found in Supplementary Figure S3. Contrary to typical impedance properties 
of metal electrodes, the conductance per unit area significantly increases with decreasing electrode 
diameter with the presented approach. To the best of our knowledge, this leads to the best results for 
current PDMS based electrodes with around 3 Ω cm2 for 30-µm ring electrodes (Figure S4)[11]. Due 
to the distinct porosity achieved with the push-through technique as seen in Figure 2d, an increased 
surface area is achieved which has a greater impact the smaller the electrode becomes. This is 
especially interesting for future studies, when the electrode shape and diameter are not pre-defined to 
a donut shape by the dimension of linear electrode arrays. 
Two different experiments were conducted to test the stability of the device. The impedance spectrum 
changed negligibly after 10,000 typical stimulation cycles (Figure 2f) as well as in an accelerated 
aging test (Figure S5). The electrode performance was also stable across weeks in vivo, as evidenced 
in the ability to record ECoG activity from all animals (six chronically implanted mice) for four to 
six weeks post implant. In a subset of three chronically implanted animals we measured the in vivo 
impedance regularly for six weeks post implantation and found that it did not change substantially 
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(Figure S5). Because the layout was transferred by imprinting the patterned membrane onto the 
PDMS during fabrication, we tested the Opto-e-Dura transparency to ensure that it was suitable for 
optical imaging. Spectrophotometry revealed over 90% transparency across the visible and near 
infrared spectrum (Figure 2g). Therefore, approximately 10% of both the excitation and emission 
light is lost leading to a reduced signal to noise ratio. However, these numbers compare favorably 
with glass and PDMS cranial windows commonly used for imaging[31]. Additionally, unlike some 
materials, such as polyimide, PDMS has exceptionally low autofluorescence in both the visible and 
near infrared ranges, making it suitable for both wide-field and 2-photon imaging[31].  
To establish the chronic biocompatibility of the implant, we performed post-mortem histology on 
coronal slices of implanted mice to investigate enhanced microglia activation by the array. Slices 
prepared 6 weeks after ECoG array implantation were stained with DAPI to visualize cell nuclei and 
immune-stained with an antibody against TMEM119 to label microglia in order to assess the degree 
to which implantation induced immune reactivity. No qualitatively difference in microglial activation 
was observed between the implanted and the non-implanted hemisphere (Figure 2h). 
 
2.4. Combined ECoG recording and wide-field calcium imaging in vivo 
To demonstrate the suitability of the arrays for multimodal data acquisition, we first performed 
simultaneous electrocorticography and wide-field calcium imaging. Arrays were chronically 
implanted over the dorsal cortex of four triple transgenic mice expressing a genetically encoded 
calcium indicator, GCaMP6f, in excitatory neurons (SNAP25-Cre; CamKIIa-tTA; TITL-
GCaMP6f)[38]. Five imaging sessions were performed two to four weeks after implantation. In each 
session, the animal was positioned to allow optical access through the Opto-e-Dura and wide-field 
imaging was performed using a standard fluorescence macroscope setup, while electrical signals were 
digitized and recorded using a commercial electrophysiology system (Figure 3a). The transparency 
of the Opto-e-Dura enabled imaging of the dorsal cortex within a circular field of view (~4 mm 
diameter), while simultaneously recording ECoG signals (Figure 3b). As expected, the ECoG 
 10
exhibited faster temporal dynamics than the simultaneously recorded fluorescence (Figure 3c), while 
imaging provided better spatial resolution and coverage, with fluorescence observable across the full 
field of view. We assessed the spatial and the temporal correspondence between the signals by 
correlating the band-limited power envelope of the ECoG signal with the percentage GCaMP6f 
fluorescence changes ( F/F) at each imaging pixel. Due to the higher temporal sampling rate of the 
ECoG compared to the wide-field signal (24 kHz, as opposed to 20 Hz), we first decomposed the 
ECoG signal into distinct frequency components (1-100 Hz) at the sampling rate of the wide-field 
imaging camera. This is permissible because, unlike the raw ECoG signal, the envelope of the power 
typically has considerably slower temporal dynamics[39]. With the band-limited power signal from 
the ECoG, we investigated the spatial (Figure 3d), and the spectral distribution (Figure 3e) of the 
covariance between the ECoG and wide-field calcium signals.  We found that the calcium signal 
showed both positive and negative peaks in correlation with the broadband ECoG signal, with positive 
peaks spatially localized to the region around the reference electrode (Figure 3d). We observed 
additional structure in the spectral domain, as illustrated in the spectrum of the shared variance across 
the four animals measured in this configuration (Figure 3e). These findings suggest intricate 
coordination across modalities as well as temporal and spatial scales, which demands further 
investigation.  
To further establish the correspondence between the signals, we performed functional mapping in 
three anesthetized, head-restrained mice using wide-field imaging while performing ECoG recording. 
The mapping experiment consisted of blocks of trials stimulating alternate sensory modalities and 
distinct portions of the body contralateral to the implant: the right whiskers, forelimb, hindlimb and 
flashes of blue light to the right eye. We were able to localize primary and secondary sensory areas 
to the expected areas of the dorsal cortex based on the selectivity of the wide-field signal 
response[35,40] (Figure 3f). Sensory responses were also present in the ECoG signal as illustrated by 
the visually evoked potentials recorded from the Opto-e-Dura (Figure 3g). We assessed the similarity 
in the topography of the visually evoked ECoG and wide-field response by comparing the magnitude 
 11
of the response across the Opto-e-Dura electrodes and the imaging field (Figure 3h). The spatial 
distribution of the ECoG and wide-field responses exhibited a high degree of correspondence across 
animals measured in this configuration (spatial correlation = 0.83 ± 0.11 mean ± SD, Spearmann rho, 
N = 3).  
 
Figure 3. In vivo wide-field calcium imaging through Opto-e-Dura. a) Schematic depicting a cross section through 
the implanted Opto-e-Dura, the wide-field imaging system and the electrophysiology amplifier. b) Photograph of 
Opto-e-Dura in place over the cortex of a chronically implanted transgenic SNAP25-GCaMP6 mouse. Colored 
circles indicate locations of example traces in panel c. c) Example of simultaneous ECoG and wide-field 
fluorescence signals exhibiting correlated dynamics with distinct time scales. ECoG signal is from electrode 
indicated in red in panel b, and calcium signal is the spatial average of the pixels indicated by the yellow circle in 
panel b). d) Spatial correlation of the total power in the ECoG signal for two example electrodes (indicated by red 
circles), with the fluorescence signal at each pixel imaged through the Opto-e-Dura. e) Spectrum of shared variance 
between the spontaneous calcium signal and the band-limited power of the ECoG signal demonstrating spectral 
structure of the correspondence. Percent of shared variance was computed using Spearman’s rank correlation, n = 
4 mice. f) Modality specific portions of cortex for four sensory stimuli overlaid on the wide-field image through the 
Opto-e-Dura. Regions reflect the boundary of peak activity derived from calcium activation maps and are colored 
to indicate stimulation according to the legend. g) Visually evoked ECoG activity for 4 example electrodes 
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(indicated in panel h) averaged over n = 20 repetitions (line width indicates standard error of the mean). Stimulus 
onset and duration indicated by grey shaded box. h) Correspondence of calcium imaging response and simultaneous 
electrical recordings to the visual stimulus. The response of the electrodes and calcium imaging is normalized and 
color-coded to illustrate the agreement between the relative amplitudes of the visually evoked potential and calcium 
responses, n = 1. Average spatial correlation between ECoG and widefield signal was 0.83 ± 0.11 (mean ± SD), 
Spearmann rho, n = 3. The white dot represents a non-functional electrode. Combined ECoG and wide-field imaging 
was performed in 5 sessions in 4 chronically implanted animals.  
 
2.5. Combined ECoG recordings and 2-photon calcium imaging in vivo 
While the combination of wide-field calcium imaging and ECoG recording can provide unique 
information about the contribution of specific cell types to the generation of macroscopic electrical 
fields, it is ultimately important to achieve single-cell, and even subcellular, resolution. In order to 
demonstrate the suitability of the Opto-e-Dura for this purpose, we performed 2-photon calcium 
imaging through the array while simultaneously measuring the ECoG signal in six sessions in four 
animals (two chronically implanted animals 2-4 weeks post implant, and two acutely implanted 
animals). We first modelled the expected loss of excitation and emission light when imaging though 
the Opto-e-Dura, as a result of opaque elements (electrodes and tracks). As expected, we found that 
light transmission is reduced for deeper focal planes (Figure 4a), resulting in smaller fields of view 
(Figure S6). In the volume less than 0.4 millimeter below the lower edge of the ECoG, it is possible 
to image a field of view of approximately 1 mm diameter (Figure S6b). Further losses in signal quality 
will occur because the ECOG structure destroys the wavefront of the excitation light beam, altering 
its focal volume and leading to a reduction in resolution, and therefore reduced 2-photon excitation 
efficiency. These effects can be mitigated by a more complicated excitation path, for example by 
including a spatial light modulator which negates the destructive effects of the ECoG on the 
wavefront. It should be noted that the focal-depth-dependent attenuation of excitation and emission 
light due to ECoG features is independent of the transmission of the PDMS reported earlier. 
Therefore, both losses will accumulate to reduce the signal to noise ratio. Losses due to the Opto-e-
Dura occur in addition to other, common optical losses, such as depth-dependent scattering, an 
exponential decrease with the tissue-dependent scattering length as parameter.[41] 
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Figure 4. In vivo 2-photon calcium imaging through Opto-e-Dura. a) Estimation of signal transmission through the 
Opto-e-Dura for the 2-photon objective at two focal depths: 0.2 mm (left) and 0.8 mm (right). Top, illustration of 
excitation beam scanning a plane through the ECoG at two focal depths. Bottom estimated transmission of light at 
two focal depths. Signal loss is depth dependent. b) Schematic depicting a cross section through the implanted Opto-
e-Dura, the 2-photon imaging system, and electrophysiology amplifier. The imaging well is filled with water and 
placement of the connector and dental cement facilitates access with the objective. c) Large field of view imaged in 
a chronically implanted animal after 2 weeks of implant. The laser was scanned in close proximity to two electrodes 
indicated by dashed, white outline. Focal depth for the image was at the lower surface of the Opto-e-Dura. Green 
square region indicates a smaller subfield imaged at a deeper focal depth in d. d) Image of fluorescence from a focal 
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plane 180 µm deeper than to the image presented in panel c, and the bottom of the Opto-e-Dura. Raster scanning 
was performed in the full field of view in close proximity to the electrode:  the left border of the field of view is < 
50 µm from the electrode, and 180 µm deeper. Shadows on the left come from the electrodes and the dark spots in 
the center are blood vessels through the cortex. e) Time series from the cells indicated by colored circles and arrow 
heads in panel d are presented in with simultaneous ECoG signal. The cells were in close proximity to the electrode: 
Cell 1 was 200 µm lateral and 180 µm deeper. The time series from the electrode is displayed and correlated events 
are visible in the traces. 
 
The placement of the ECoG, imaging well, and connector permitted access with the water-dipping 2-
photon objective (Figure 4b) and it was possible to image in the vicinity of ECoG electrodes and 
tracks without excessive reflectance or electrical artifact (Figure 4c). We did not observe electrical 
artifacts as a result of scanning the laser across the Opto-e-Dura, unless the laser scanned within 50 
µm of a conductive feature of the ECoG, such as an electrode or track. The depth of the imaging plane 
is also limited by the dimensions of the PDMS well and the working distance of the objective. In our 
preparation, we were able to image a field of view of size 0.5 mm to a depth of 0.4 mm from the 
bottom edge of the Opto-e-Dura. It was not possible to image deeper without disturbing the ECoG 
array, as the objective would approach the sides of the imaging well. More specifically, neurons could 
be imaged in the vicinity of recording electrodes (within 200 µm lateral from the nearest electrode 
and 180 µm deeper) while simultaneously measuring ECoG signals (Figure 4d). In general, 2-photon 
calcium imaging through the Opto-e-Dura captured high-resolution single-cell recordings down to 
several hundred micrometers from the cortical surface, with simultaneous, high temporal resolution, 
multichannel ECoG signals.  
 
2.6. Combined ECoG and penetrating multi-electrode arrays in vivo 
In addition to optical and electrical recordings from superficial cortex, an ideal device would enable 
dense, MEA recordings. Due to the soft and elastic character of PDMS we were able to penetrate the 
Opto-e-Dura with sharp, MEAs. The combination of ECoG with MEA recording facilitates multi-
scale measurements across the large area covered by the Opto-e-Dura and dense recording from the 
cortex and deep structures. To demonstrate the suitability of the arrays for combined surface and 
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depth recordings, we acutely placed a multi-site linear silicon array through the Opto-e-Dura in five 
sessions in three chronically implanted animals, one to five weeks after implant (Figure 5a). 
Similarly, injection cannulas or micropipettes could be inserted through the ECoG to deliver viruses, 
dyes, or drugs to the cortex or deeper structures. Here, we coated the linear probe with dye to 
reconstruct its track through cortex and into hippocampus (Figure 5a). We reliably performed 
multiple insertions (up to 10 times at various locations) of MEAs through the ECoG and recorded 
activity across multiple cortical and subcortical regions (Figure 5b). The maximally achievable depth 
of insertion is defined by the length and geometry of the array probe, the size of the connector and 
headstage, and the geometry of the imaging well. 
 
Figure 5. In vivo penetration of Opto-e-Dura for simultaneous surface and depth electrophysiology. a) Histological 
image of a post-mortem slice from a chronically implanted SNAP25 mouse. Green indicates fluorescence from 
GCaMP6f in neurons expression SNAP25 and red indicates fluorescence from the lipophilic dye DiD. The position 
of the Opto-e-Dura is depicted and the placement of the acutely placed linear electrode array is illustrated based on 
DiD labelling. Borders of cortex and hippocampus are overlaid by registration of the histological section with an 
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atlas. b) Schematic of the linear electrode array penetrating the Opto-e-Dura, cortex and hippocampus in close 
proximity to an ECoG electrode. Example raw voltage traces from acute linear array. c) Spatial maps displayed on 
the opto-e-dura of the correlation between the ECoG signal and the LFP from the linear array at three depths. Opto-
e-Dura electrodes are color coded to indicate the correlation at each electrode with the LFP signal at the indicated 
depth. As expected, the correlation reverses across cortical sites from superficial to deep and is attenuated for the 
deepest sites in the hippocampus. d) Single unit activity recorded from cortex on the linear array. Left, high-pass 
filtered voltage trace from the linear array showing an example single unit indicated by red voltage deflections. 
Right, the waveform of the single unit indicated on the left. e) Spike-triggered voltage of the ECoG is illustrated 
spatially across the array for the cortical unit in shown in d. Each ECoG electrode is colored to indicate the average 
voltage at four time points centered on action potentials from the cortical unit. In the vicinity of the linear array, a 
spatially localized variation in voltage precedes the spike. f) Phase locking of cortical spikes to the ECoG signal. 
Left, locking of the single unit shown in d to three example ECoG electrodes estimated by the pair-wise phase 
consistency (PPC) measure. The cortical unit is strongly locked to slow (~1 Hz) variations in nearby ECoG 
electrodes, but the locking breaks down over distance. ECoG electrodes indicated with numbers are displayed on 
the schematic of the opto-e-dura in panel E. Right, example traces for 10 seconds showing multiple slow network 
events occurring synchronously across cortex and the hippocampus. ECoG activity is shown along with LFP from 
the linear array at the locations in panel c, as well as action potentials from 4 isolated cortical single units. Slow 
events repeat with a periodicity ~ 1 second, as measured by PPC.  
 
We investigated the correspondence of the ECoG signal to depth recordings for both population 
activity (LFP) and single cells (SUA). We quantified the spatial and temporal characteristics of the 
correspondence using correlations, similar to the comparison of the wide-field calcium signal to the 
ECoG (Figure 5c-f). We first quantified how the spatial distribution of ECoG activity was related to 
the LFP from different depths along the linear array. We performed a partial correlation analysis for 
each ECoG channel with the LFP from each electrode on the MEA. We found that the correlation 
showed both positive and negative peaks, with the peak of correlation on the ECoG array occurring 
in close proximity to the position of the MEA (Figure 5c). Further, we found that this relationship 
varied with depth, diminishing for deeper positions. Finally, we investigated the relationship of the 
spiking activity of single cortical neurons to the ECoG signal. We isolated single cortical units from 
the MEA and quantified the spatial distribution of ECoG activity in the time period around action 
potentials. We found that a wave of surface positivity preceded action potentials, followed by a 
surface negativity coinciding with the action potential in the vicinity of the MEA (Figure 5e). To 
investigate the spectral characteristics of this synchronization, we estimated the frequency-resolved 
 17
phase-locking between cortical action potentials and the ECoG signal. We found that cortical action 
potentials recorded on the MEA were consistently phase-locked to the ECoG signal in a topographical 
manner, peaking at ECoG sites near the array and falling off with distance The locking had specific 
spectral structure, peaking around 1 Hz, related to cortical Up-Down state transitions (Figure 5f, left). 
Example traces of simultaneous ECoG, LFP and SUA demonstrate a series of Up-Down state 
transitions and illustrate additional structure in depth along the MEA (Figure 5f, right). Cortical LFP 
was highly correlated to the proximal ECoG electrode and phase locked to cortical single units, while 
hippocampal LFP exhibited distinct activity patterns anti-correlated with the profile in the cortex. 
Combined ECoG and electrode array recordings thus enable multi-scale investigation of local and 
distributed dynamics, which can be performed repeatedly across days in chronically implanted 
animals, across behaviorally relevant time-scales. 
 
3. Conclusion 
We designed, fabricated, and validated the Opto-e-Dura, a PDMS-based ECoG array that enables 
multimodal, multi-scale neuroscience. Using PDMS as a base material, the device is transparent, 
elastic, biocompatible, and chronically stable for weeks in mice. These features facilitate multimodal 
experiments that combine ECoG recordings with optical imaging and repeated recordings from 
penetrating MEAs. The ability to flexibly combine diverse measurement modalities in the same 
animal enhances the versatility of experimental approaches and facilitates multimodal experiments 
comprising techniques with complementary strengths. We found rich, highly structured 
correspondences between the diverse signals we measured at all spatial and temporal scales. 
Comparisons revealed both spatial and temporal specificity and pointed towards future directions for 
investigating the basis of the ECoG signal. The correspondence between ongoing variations in the 
time resolved power of the ECoG signal and both the calcium activity and local single unit activity 
suggests a path towards better understanding this important macroscopic signal in terms of the 
contributions of specific cell types and even individual cells. Moreover, additional studies could 
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further explore these relationships to provide a better understanding of both the wide-field calcium 
signal and electrical oscillations in specific frequency ranges by revealing the involvement of specific 
cellular populations. 
Future applications of the opto-e-dura could use the approaches presented here in concert. For 
example, large-scale functional mapping could be performed using the ECoG and wide-field imaging, 
and the derived maps could localize regions of interest and their topography. Specific populations 
could be subsequently selected according to their response properties and targeted for viral injections, 
drug delivery, or dense recording with 2-photon imaging or MEAs. Such studies enable the 
simultaneous recording of distributed surface activity, in combination with depth-resolved recordings 
of targeted populations. Compared with previous attempts at multimodal, multi-scale studies, our 
approach enables stable, chronic access in awake animals. In chronically implanted animals, 
experiments can track local and distributed dynamics during the performance of behavioral tasks or 
the acquisition of novel skills. It is possible to perform repeated imaging or repeated penetrations 
with MEAs across large portions of the brain without the need for additional invasive surgery or 
anesthesia. While the presented arrays were robust and chronically stable, enabling electrical and 
optical access to targeted brain regions for multiple weeks (2-4 weeks), future work will be necessary 
to improve implantation procedures and the long-term stability of the device, as well as increase the 
density and decrease the size of electrodes. Additionally, the elasticity of the device can be further 
leveraged to enable penetration with stimulating electrodes or micro-syringes for targeted injection 
or drug application. The transparency of the Opto-e-Dura also make it an appealing interface for use 
with optogenetic activation or silencing studies where light can be delivered to local portions of the 
cortex, or perturbation experiments where light is raster-scanned across the array to determine regions 
engaged in a particular task. Overall the Opto-e-Dura demonstrates the evolving potential of 
stretchable electronics for next-generation brain-machine interfaces. 
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4. Experimental Section 
ECoG fabrication: Two PVDF membranes were patterned with an established photolithography 
process (Tybrandt et al. 2016) (microresist technology ma N-490, 4acc, 60s, 3.4 krpm for track and 
3 krpm for electrode layer), one for the track layer and one for the electrodes. Subsequently, recently 
published Au NWs[11] were filtered onto the pre-wetted track layer membrane. For the electrode layer, 
a 1 bead thick layer of PMMA beads (0.71 µm, Bangs Laboratories Inc.) was filtered prior to the Pt 
particles (Goodfellow, 3.5 µm) to lower adhesion to the membrane and increase the porosity as they 
are dissolved after PDMS curing. The bottom PDMS layer of roughly 60 µm thickness (Sylgard184 
DowCorning) was spincoated (1 krpm, 30 s) on a silanized borosilicate 2-inch wafer and semi-cured 
for 3.5 minutes on a hotplate at 75°C before transferring the Au NW layer. After curing an additional 
10 minutes at 75°C, the second PDMS layer with a thickness of around 15 µm (5.5 krpm, 60 s) was 
spin coated on top. This layer was pre-cured for 3 minutes at 75°C to permit penetration with the Pt 
particle layer in order to establish contact with the underlying Au NW tracks. After aligning the Au 
NW tracks with the electrode layer on an x, y, z stage, they were brought in contact and a force was 
applied to press the Pt particle electrodes through the top semi-cured PDMS layer and into contact 
with the Au NW tracks. The force must be tuned in order to achieve both good contact between the 
electrodes and tracks and the desired height for the final electrodes. The device was then cured for 20 
minutes at 80°C before removing the electrode layer membrane by dissolving the photoresist with 
acetone and fully curing the device overnight at 80°C. The implant was cut in shape with a scalpel 
and carefully removed from the wafer. It was then mounted on a custom PCB by stencil printing 
silver epoxy on the contacts and securing it with epoxy glue. An Omnetics nano connector (part 
number A76284-001) was soldered to the other side of the PCB to minimize the size and weight of 
the device. 
 
Device characterization: All electrochemical measurements prior to implantation were conducted 
with a potentiostat (Autolab, Metrohm), in a 3-electrode configuration with an Ag/AgCl reference 
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electrode, a Pt wire counter electrode and PBS as electrolyte. Before every impedance measurement, 
six voltammetry cycles between -0.6 – 0.8 V were run at 0.2 V/s on each electrode to assure a stable 
interface. The impedance measurements were taken in the range of 1-100 kHz at 50 points. The 
equivalent circuit was determined and fitted with the Nova 2.1.2 software. 
 
Preparation for implantation: Prior to implantation (within 30 minutes), each array was conditioned 
with a procedure to improve in vivo performance and increase signal by establishing a stable electrode 
double layer and vacate air trapped in the porous electrode structure. The conditioning protocol 
consisted of voltage sweeps between -0.6 – 0.8V for at least 20 repetitions. 
 
Animals and surgical procedures: All methods in mice were carried out according to the guidelines 
of the Veterinary Office of Switzerland and following approval by the Cantonal Veterinary Office in 
Zurich (license 133/2015). A total of eight adult male mice (4-10 months old) were used in this study, 
six mice were chronically implanted for 3-6 weeks and two were implanted acutely for 6 hours. Mice 
were triple transgenic SNAP25-Cre;CamK2a-tTA; TITL-GCaMP6f animals, expressing GCaMP6f 
in excitatory neurons. To generate triple transgenic animals, double transgenic mice carrying 
CamK2a-Tta[42] and TITL-GCaMP6f[38] were crossed with a SNAP25-Cre line[43] individual lines are 
available from The Jackson Laboratory as JAX# 016198, JAX#024103, and JAX# 022864, 
respectively). Mice were anesthetized with isoflurane (in pure O2, 2% for induction, 1.5% for surgery) 
and body temperature was maintained at 37°C. Local analgesia (lidocaine 1%) was applied topically, 
and the skull was exposed and cleaned to provide access the entire dorsal surface. A thin layer of 
adhesive (iBond; UV-cured) was distributed across the dry surface of the skull and dental acrylic 
(Charisma) was used to form a wall around the left hemisphere. A thin layer of dental cement was 
then distributed homogenously over the exposed skull (Tetric EvoFlow A1). Next, a small hole (< 
0.5 mm) was drilled over the cerebellum to allow placement of the reference electrode. We performed 
a 5-mm diameter craniotomy, centered over the left somatosensory cortex. The dura mater was 
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removed while irrigating with Ringer solution to avoid drying or heating. The ECoG was held with a 
stereotaxic arm and positioned over the craniotomy. Once the ECoG was positioned, the connector 
PCB was secured to the edge of the skull, atop the acrylic wall with additional dental cement. The 
ECoG array was then held in place by a glass capillary covered by a blunt, plastic pipette tip. While 
the ECoG was held flush with the surface of the brain with gentle pressure, dental cement was applied 
to hold it in position flush with the skull. A small PDMS well was secured to the ECoG with additional 
PDMS layer applied at the interface to allow imaging through the ECoG with a water-immersion 
objective. The reference was placed in the hole over the cerebellum and fixed with dental cement. 
Finally, a metal post for head fixation was affixed to on the back of the right hemisphere with dental 
cement. Mice were housed individually after implantation to avoid damage to each other or the 
implant. 
 
ECoG recording from Opto-e-Dura: Mice were head-fixed after habituation to restraint. The array was 
connected to a multiplexing headstage and multichannel amplifier (RHD2000 Intan) and in vivo 
impedance was measured, after which ECoG signals were recorded onto a desktop PC. ECoG signals 
were sampled at 20 kHz and offline filtering was performed. ECoG data were low pass filtered with 
a second order Butterworth filter below 200 Hz and down sampled to 1 kHz. For recordings under 
anesthesia, animals were first anesthetized using isoflurane (1%) and body temperature was 
maintained at 37°C using a heating pad. 
 
Wide-field calcium imaging: To demonstrate the suitability of the Opto-e-Dura for combination with 
optical methods, we first performed wide-field calcium imaging from the dorsal cortex while 
simultaneously acquiring electrophysiological signals from the ECoG. The wide-field imaging 
system and methods have been described previously[35]. Briefly, a sensitive CMOS camera 
(Hamamatsu Orca Flash 4.0) was mounted on top of a dual objective setup. Two objectives (Navitar; 
top objective: D-5095, 50-mm focal length, f/# 0.95; bottom objective inverted: D-2595, 25-mm focal 
length, f/# 0.95) were interfaced with a dichroic mirror (510 nm; AHF; Beamsplitter T510LPXRXT) 
 22
inside a filter cube (Thorlabs). This combination allowed a ~9 mm field-of-view, covering most of 
the dorsal cortex of the one hemisphere. Blue LED light (470 nm; M470L3; Thorlabs) was guided 
through an excitation filter (514/30 nm BrightLine HC) and a diffuser, collimated, reflected from the 
dichroic mirror, and focused through the bottom objective approximately 100 µm below the blood 
vessels. Green light emitted from the preparation passed through both objectives and an emission 
filter (515/30 nm) before reaching the camera. The total power of blue light on the preparation was 
<5 mW, i.e., <0.1 mW/mm2. At this illumination power we did not observe electrical artifacts on the 
ECoG, nor photobleaching of the fluorescent indicator. Data was collected with a temporal resolution 
of 20 Hz and a spatial resolution of 512×512 or 2048×2048 pixels. On each imaging day a green 
reflectance image was taken (fiber-coupled LED illuminated from the side; Thorlabs) as reference to 
capture blood vessel patterns. 
 
Functional localizer for mapping of the cortex covered by the Opto-e-Dura: Each mouse underwent a 
mapping session under anesthesia (1% isoflurane), in which we presented four different sensory 
stimuli: tactile stimulation with a moving bar touching either multiple whiskers, or the forelimb or 
the hindlimb (25 Hz for 2 s), and visual stimulation with a blue LED in front of the eye (100-ms 
duration flashes). The averaged evoked maps showed activation patches in the expected areas[40] 
(Figure 4c), which were used to define the general borders of sensory areas. These locations allowed 
us to confirm the location of the array on the brain, and provided a basis for assessing the 
correspondence between electrical signals recorded on the ECoG array and in the bulk fluorescence 
signals of the calcium indicator. 
 
Two-photon calcium imaging: In two mice, we acquired two-photon imaging data. We used a 
Scientifica two-photon microscope controlled by ScanImage, equipped with a Ti:sapphire laser (Mai 
Tai HP; Newport Spectra Physics), a water-immersion objective (Nikon 16x LWD-PF, NA 0.8,3-mm 
working distance), galvanometric scan mirrors, and a Pockel’s Cell (Conoptics) for laser intensity 
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modulation. We excited GCaMP6f at 940 nm and detected green fluorescence with a photomultiplier 
tube (Hamamatsu). Images (256×128 pixel) were acquired at 3-Hz frame rate and tens of cells per 
field of view were imaged simultaneously. 
 
Linear electrode recordings: To test penetration of the Opto-e-Dura with a sharp linear electrode array, 
we used a 32-contact silicon array (15 micron Iridium Oxide contacts and 50 micron site spacing, 
model E32-50-S1-L6 NT, Atlas Neurotechnologies). Prior to insertion, the array was dipped in a 
lipophilic fluorescent dye (DiD molecular probes) to enable post-mortem localization. The array was 
subsequently attached to a mechanical micro-drive (Narishige) and inserted through the ECoG and 
into the brain. Data from the 32-contact linear array were recorded by a second headstage connected 
to the same multichannel amplifier used to record the ECoG (RHD2000 Intan). Recordings were 
made at various locations through the Opto-e-Dura, both adjacent to ECoG electrodes and in the center 
of the array.  After awake recordings were performed, additional measurements were made in 
anesthetized animals with isoflurane (1%). During dual recordings with ECoG and linear arrays, all 
electrophysiological data were acquired at 30 kHz and filtered into low and high frequency activity 
offline. Both ECoG and LFP data were low pass filtered with a fourth order Butterworth filter below 
200 Hz and down sampled to 1 kHz. The data from the linear array were additionally filtered into a 
high frequency component using a fourth order Butterworth bandpass (0.64 – 6 kHz). Single unit 
activity was extracted by a taking only the largest unit with amplitude at least larger than 5 times the 
standard deviation of the high pass signal.  
 
Statistical analysis: Data analysis was performed using Matlab software (Mathworks). 
Wide-field fluorescence images were sampled down to 256×256 pixels and pixels outside the imaging 
area were discarded. Each pixel and each trial were normalized to baseline several frames before the 
first auditory cue (frame 0 division). To study neural dynamics during sensation, we used a different 
baseline, several frames before the relevant stimulus. Electrical and optical signals were processed 
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using in-house software. For comparison of ECoG and calcium signals, ECoG was decomposed into 
time-resolved power envelopes using the fast Fourier transform with a Hann-tapered window with a 
length dependent on the frequency (5 cycles) and a temporal resolution to match the simultaneous 
calcium recording. Calcium time-series and the band-limited enveloped from the ECoG were then 
correlated using the Spearmann rank correlation because both power and F/F are strictly positive. 
Spike locking was computed between single units isolated as described above and the simultaneous 
ECoG signal using the pairwise phase consistency metric[44]. The Fourier components of ECoG data 
centered on spikes were computed in frequency-dependent windows (5 cycles) after applying a 
Hanning taper. The mean length of the resultant vector from all pairs of Fourier components for a 
given unit provide a metric of the phase locking.  
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Supporting Information 1 
Figure S1. Determination of Pt pillar height regarding the various Pt particle concentrations. For the here presented 2 
electrodes a concentration of 4 mg per surface area was chosen to gain electrode pillars of roughly 20 µm. 3 
4 
Figure S2. Impact of full ECoG device thickness on the impedance a) 75 μm thick and b) 33 μm thick ECoG arrays. 5 






















Figure S3. Equivalent circuit for the ECoG electrodes fitted in blue for the phase and red for the impedance to the 9 
corresponding black measurement values. The circuit consists of R1 (730 Ω), the resistance for electronics and 10 
electrolyte in series with an transmission line model from Bisquert[45] with R2 (24.8 MΩ) the electrolyte resistance 11 
of the pore, R3 (740 MΩ) accounting for the pore resistance and  Q (553 mMho*s0.834) the constant phase element, 12 
while L, indicating the pore length was set to 20E-6. However, due to the complexity of the porous electrode-13 
electrolyte it is a simplified circuit. 14 
 15 
Figure S4. Due to the high surface area of porous Pt electrodes a significantly decreased impedance to area 16 
performance was achieved with the here presented fabrication technique. This was the case for electrode of A) 100 17 
μm diameter with roughly 6.66 Ωcm2 at 1 Hz and B) electrodes with roughly 30 μm in diameter achieving 1.14 18 
Ωcm2 at 1Hz, being the lowest value documented for stretchable electrodes. 19 
 3 
20 
Figure S5. a) Stability test of electrodes for 21 days at 85°C in PBS, with impedance data from day 1 (black) and 21 
day 21 (blue). The increased impedance in day 21 can be explained by an overall higher electrolyte impedance, as 22 
it is a constant increase over all frequencies. b) In vivo impedance data over 38 days, n = 32 electrodes. c) CV and 23 
d) Impedance of test electrodes before and after stretching up to 20% for 1,000 repetitions. 24 
 25 
Figure S6. Estimation of signal loss and field of view through Opto-E-Dura. a) Estimated transmission of light 26 
through two cross sections. The array is depicted in the center panel, with cross-sections indicated in red. Top, 27 
estimate of light transmission in a horizontal cross section of the array as a function of focal depth relative to the 28 
array. Right, estimate of light transmission in a vertical cross section of the array as a function of focal depth relative 29 
to the array. b) Estimated field of view diameter with transmission greater than 80% at depths from 0.1 to 1 mm. 30 
